Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Testosterone: Functions and Regulation01:26

Testosterone: Functions and Regulation

3.3K
The intricate hormonal interplay essential for male reproductive health begins with the release of gonadotropin-releasing hormone (GnRH) by the hypothalamus. This hormone prompts the pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). LH targets the Leydig cells in the testes, stimulating them to produce and release testosterone. In concert with testosterone, FSH acts on the Sertoli cells within the seminiferous tubules to facilitate the release of...
3.3K
Menopause01:28

Menopause

5.0K
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
5.0K
Disorders of the Male Reproductive System01:20

Disorders of the Male Reproductive System

5.2K
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
5.2K
Signs of Puberty01:27

Signs of Puberty

2.1K
Puberty is a critical phase, typically beginning between the ages of 8 and 13 in girls and 9 and 14 in boys, though timing can vary based on genetics, environmental factors, and overall health. This period is characterized by the development of secondary sexual characteristics and the attainment of reproductive potential. Endocrine changes underpin puberty, with hormonal surges of Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH) instigated by Gonadotropin-Releasing Hormone (GnRH)...
2.1K
The Mantel-Cox Log-Rank Test01:19

The Mantel-Cox Log-Rank Test

1.2K
The Mantel-Cox log-rank test is a widely used statistical method for comparing the survival distributions of two groups. It tests whether a statistically significant difference exists in survival times between the groups without assuming a specific distribution for the survival data, making it a non-parametric test. This flexibility makes the log-rank test particularly valuable in medical research and other fields where the timing of an event, such as death or disease recurrence, is of...
1.2K
Life Tables01:22

Life Tables

665
A life table is a statistical tool that summarizes the mortality and survival patterns of a population, providing detailed insights into the likelihood of survival or death across different age intervals within a cohort. By organizing data on survival probabilities and mortality rates, life tables offer a clear snapshot of population dynamics over time. They are extensively used in demography, public health, actuarial science, and ecology to analyze life expectancy, design health interventions,...
665

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Androgen Society Position Paper on Cardiovascular Risk With Testosterone Therapy.

Mayo Clinic proceedings·2024
Same author

Monitoring thyroid function during amiodarone use.

British journal of hospital medicine (London, England : 2005)·2024
Same author

European Association of Urology Guidelines on Penile Size Abnormalities and Dysmorphophobia: Summary of the 2023 Guidelines.

European urology focus·2023
Same author

Leflutrozole in male obesity-associated hypogonadotropic hypogonadism: Ph 2b double-blind randomised controlled trial.

European journal of endocrinology·2023
Same author

The British Society for Sexual Medicine Guidelines on Male Adult Testosterone Deficiency, with Statements for Practice.

The world journal of men's health·2023
Same author

European Association of Urology Guidelines on Sexual and Reproductive Health-2021 Update: Male Sexual Dysfunction.

European urology·2021

Related Experiment Video

Updated: Apr 26, 2026

Combining Behavioral Endocrinology and Experimental Economics: Testosterone and Social Decision Making
11:51

Combining Behavioral Endocrinology and Experimental Economics: Testosterone and Social Decision Making

Published on: March 2, 2011

14.7K

Testosterone and mortality.

Vakkat Muraleedharan1, T Hugh Jones

  • 1Robert Hague Centre for Diabetes & Endocrinology, Barnsley Hospital, NHS Foundation Trust, Barnsley; Department of Human Metabolism, University of Sheffield Medical School, Sheffield, UK.

Clinical Endocrinology
|July 22, 2014
PubMed
Summary
This summary is machine-generated.

Low testosterone levels in men increase mortality risk, particularly from cardiovascular disease. While low testosterone is a biomarker for poor health, its role in disease progression and the benefits of testosterone replacement therapy remain under investigation.

More Related Videos

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

13.4K
Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.3K

Related Experiment Videos

Last Updated: Apr 26, 2026

Combining Behavioral Endocrinology and Experimental Economics: Testosterone and Social Decision Making
11:51

Combining Behavioral Endocrinology and Experimental Economics: Testosterone and Social Decision Making

Published on: March 2, 2011

14.7K
A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

13.4K
Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.3K

Area of Science:

  • Endocrinology
  • Epidemiology
  • Cardiovascular Medicine

Background:

  • Epidemiological studies link low endogenous testosterone levels in men to increased mortality risk.
  • Cardiovascular disease, cancer, and respiratory conditions are leading causes of death in men with low testosterone.

Purpose of the Study:

  • To review the current evidence on the relationship between testosterone deficiency and various diseases.
  • To explore whether testosterone deficiency is a direct cause or a biomarker of ill health.
  • To discuss the controversial role of testosterone replacement therapy in disease progression and survival.

Main Methods:

  • Review of epidemiological and disease-specific studies.
  • Analysis of the association between testosterone levels, disease prevalence, and mortality.
  • Discussion of existing literature on testosterone replacement therapy outcomes.

Main Results:

  • Low testosterone is a convincing biomarker for disease severity and mortality.
  • Testosterone deficiency is associated with adverse cardiovascular risk factors, potentially promoting atherosclerosis.
  • Evidence suggests improved survival in hypogonadal men treated with testosterone replacement therapy, though this remains controversial.

Conclusions:

  • Low testosterone is strongly associated with increased mortality and serves as a biomarker for underlying health issues.
  • The direct role of testosterone deficiency in disease pathogenesis requires further investigation.
  • Testosterone replacement therapy's impact on clinical outcomes and survival is an area of ongoing debate and research.